Therefore, this study evaluated a large spectrum of circulating molecules in serum of cancer patients prior to start anti-PD-1 treatment including cytokines, chemokines, soluble immune checkpoints, molecules of adhesion and indoleamine-2,3-dioxygenase (IDO) activity. Here, PDCD1 is linked to cancer.